LINC-PINT and neoplasm: Long intergenic non-protein coding RNA, p53-induced transcript (LINC-PINT), also known as MKLN1 antisense RNA 1 (MKLN1-AS1), was initially found to serve as a tumor suppressor in colon cancer11, and then be bolstered strongly in pancreatic ductal adenocarcinoma, lung cancer, and osteosarcoma12–14.